v3.25.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Assets    
Cash and cash equivalents $ 105,525 $ 59,968
Restricted cash 93,409 154,657
Loans receivable at fair value 2,874,092 2,778,523
Capitalized software and other intangibles, net 71,698 86,588
Right of use assets - operating 9,441 9,775
Other assets 103,691 137,592
Total assets 3,257,856 3,227,103
Liabilities    
Secured financing 199,384 535,469
Asset-backed notes at fair value 263,799 1,080,690
Asset-backed borrowings at amortized cost 2,192,649 984,333
Acquisition and corporate financing 143,663 203,751
Lease liabilities 11,468 18,200
Other liabilities 56,811 50,851
Total liabilities 2,867,774 2,873,294
Note 15 Leases, Commitments and Contingencies
Stockholders' equity    
Common stock, $0.0001 par value - 1,000,000,000 shares authorized at December 31, 2025 and December 31, 2024; 44,709,065 shares issued and 44,437,042 shares outstanding at December 31, 2025; 36,383,879 shares issued and 36,111,856 shares outstanding at December 31, 2024 8 7
Common stock, additional paid-in capital 623,668 612,642
Accumulated deficit (227,285) (252,531)
Treasury stock at cost, 272,023 and 272,023 shares at December 31, 2025 and December 31, 2024 (6,309) (6,309)
Total stockholders’ equity 390,082 353,809
Total liabilities and stockholders' equity $ 3,257,856 $ 3,227,103

Source